Our Pricing

Mounjaro 15mg: UK Pharmacy Pricing & Clinical Guide

When comparing mounjaro 15mg price uk pharmacy options, Cured Pharmacy offers transparent pricing from £135.00 with no hidden consultation fees. As a GPhC-registered pharmacy (9012511), we provide genuine UK-licensed Mounjaro alongside free clinical assessment by UK prescribers, ensuring safe access to this advanced dual-receptor weight loss treatment.

Understanding Mounjaro 15mg: Clinical Mechanism and Efficacy

Mounjaro 15mg contains tirzepatide, the first dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the MHRA for weight management [1]. This dual-receptor activation distinguishes tirzepatide from single-pathway GLP-1 treatments, producing enhanced metabolic effects through complementary mechanisms that regulate appetite, glucose homeostasis, and energy expenditure.

The 15mg dose represents the maximum maintenance strength in the tirzepatide dosing schedule, typically reached after gradual dose escalation from 2.5mg over several months. In the SURMOUNT-1 trial, participants receiving tirzepatide 15mg achieved mean body weight reductions of 22.5% over 72 weeks, compared to 2.4% with placebo [1]. This magnitude of weight loss significantly exceeds results observed with earlier GLP-1 monotherapy agents, positioning Mounjaro as a leading pharmacological option for obesity management in the UK.

The medication works by enhancing insulin secretion in a glucose-dependent manner, suppressing inappropriate glucagon release, slowing gastric emptying, and reducing appetite through central nervous system pathways [2]. These combined effects create a favourable metabolic environment for sustained weight reduction when used alongside dietary modification and increased physical activity, as recommended by NICE guidelines for obesity treatment.

Mounjaro 15mg Price UK Pharmacy: What Affects Your Cost

At Cured Pharmacy, Mounjaro 15mg is priced at £135.00 per pen, with transparent costs displayed before you complete your clinical assessment. Unlike some providers who add consultation fees or membership charges, our pricing structure includes the medication, UK prescriber review, and discreet delivery to your address.

The total cost of your Mounjaro treatment depends on your prescribed dose and duration. Most patients begin at 2.5mg and increase gradually every four weeks, reaching 15mg after approximately 16-20 weeks if clinically appropriate [3]. Your UK prescriber will determine the optimal dose escalation schedule based on your response, tolerability, and weight loss progress during monthly reviews.

Several factors influence whether 15mg is the right maintenance dose for you. Clinical trials demonstrate that higher doses produce greater weight reduction, but individual tolerance varies [1]. Some patients achieve their target weight at lower maintenance doses such as 10mg, whilst others require 15mg for optimal therapeutic effect. Your prescriber will assess efficacy markers including weight trajectory, side effect profile, and metabolic parameters to personalise your treatment plan.

Prescription Requirements and Clinical Assessment

Mounjaro is a prescription-only medicine in the UK, requiring clinical assessment by a registered prescriber before dispensing. Our online consultation takes under three minutes and covers your medical history, current medications, weight loss goals, and contraindications. Superintendent Pharmacist Tarun Kumar (GPhC 2233073) and our clinical team review every assessment to ensure Mounjaro is safe and appropriate for your circumstances.

The MHRA license for Mounjaro specifies use in adults with a body mass index (BMI) of 30 kg/m² or greater, or 27 kg/m² or greater in the presence of at least one weight-related comorbidity such as hypertension, type 2 diabetes, or dyslipidaemia [3]. Your prescriber will verify these criteria during assessment and may request additional information if your clinical history requires further evaluation before approval.

Mounjaro 15mg vs Wegovy: Comparative Clinical Evidence

Both Mounjaro (tirzepatide) and Wegovy (semaglutide) are once-weekly injectable treatments licensed in the UK for chronic weight management, but their pharmacological profiles differ significantly. Wegovy activates only GLP-1 receptors, whilst Mounjaro's dual GIP/GLP-1 mechanism produces enhanced metabolic effects in head-to-head comparisons [4].

The SURPASS-2 trial directly compared tirzepatide against semaglutide 1mg in patients with type 2 diabetes, demonstrating superior weight reduction with tirzepatide across all dose levels [4]. Participants receiving tirzepatide 15mg lost an average of 12.4 kg compared to 6.2 kg with semaglutide 1mg over 40 weeks. Whilst this study used the diabetes-licensed semaglutide dose rather than the higher 2.4mg Wegovy dose, the magnitude of difference suggests tirzepatide's dual-receptor activity confers meaningful clinical advantages.

Tolerability profiles are broadly similar between the two medications, with gastrointestinal side effects such as nausea, diarrhoea, and constipation representing the most common adverse events [1][2]. Both require gradual dose escalation to minimise these effects. Your UK prescriber will consider your previous experience with GLP-1 medications, treatment goals, cost considerations, and medical history when recommending between Mounjaro and alternative options available at Cured Pharmacy.

Starting Mounjaro 15mg: Dose Escalation and Timeline

The recommended Mounjaro initiation schedule begins at 2.5mg once weekly for four weeks, then increases to 5mg for four weeks, 7.5mg for four weeks, 10mg for four weeks, 12.5mg for four weeks, and finally 15mg as the maximum maintenance dose [3]. This gradual escalation minimises gastrointestinal side effects whilst allowing your body to adapt to tirzepatide's metabolic effects.

Most patients reach the 15mg maintenance dose after 20 weeks (approximately five months) of treatment. However, your prescriber may adjust this timeline based on your individual response and tolerance. Some patients maintain excellent weight loss at 10mg or 12.5mg and may not require escalation to 15mg, whilst others benefit from the maximum dose to achieve their clinical goals.

Each Mounjaro pen contains four weekly doses at your prescribed strength. You'll inject subcutaneously into your abdomen, thigh, or upper arm once weekly on the same day each week, rotating injection sites to reduce local reactions. The KwikPen device is pre-filled and designed for ease of use, with clear dosing windows and simple administration steps detailed in the patient information leaflet included with your medication.

Monitoring and Follow-Up During Treatment

Regular monitoring ensures Mounjaro remains safe and effective throughout your treatment journey. Your prescriber will schedule monthly reviews to assess weight loss progress, side effect management, and any necessary dose adjustments. These consultations also provide opportunity to discuss dietary strategies, physical activity goals, and behavioural modifications that enhance pharmacological treatment outcomes.

Clinical guidelines recommend evaluating treatment response after 16 weeks at the maximum tolerated dose [3]. If you've achieved less than 5% weight loss at this point, your prescriber may reassess whether Mounjaro is the optimal treatment for you or whether alternative approaches should be considered. Most patients on 15mg maintenance therapy experience continued weight reduction beyond this timeframe, with peak effects typically observed between 60-72 weeks in clinical trials [1].

Mounjaro 15mg Side Effects and Safety Considerations

The most frequently reported side effects with Mounjaro 15mg are gastrointestinal in nature, including nausea (affecting up to 29% of patients), diarrhoea (21%), vomiting (12%), and constipation (11%) in clinical trials [1]. These effects are generally mild to moderate in severity, occur predominantly during dose escalation phases, and diminish over time as tolerance develops. Taking Mounjaro with food, staying well-hydrated, and eating smaller meals can help manage these symptoms.

Serious adverse events are uncommon but require awareness. Tirzepatide carries warnings for potential pancreatitis, gallbladder disease, acute kidney injury (usually secondary to dehydration from gastrointestinal effects), and hypoglycaemia when used with insulin or sulfonylureas [3]. Your prescriber will review your medical history for risk factors including previous pancreatitis, gallstones, or significant renal impairment before prescribing Mounjaro.

Mounjaro is contraindicated in patients with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, based on thyroid C-cell tumour findings in rodent studies [3]. Whilst no causal relationship has been established in humans, the MHRA advises against use in these populations as a precautionary measure. Women of childbearing potential should use effective contraception during treatment, as tirzepatide's effects on pregnancy outcomes remain incompletely characterised.

Why Choose Cured Pharmacy for Mounjaro 15mg

As a GPhC-registered online pharmacy (registration 9012511), Cured Pharmacy dispenses only genuine UK-licensed Mounjaro sourced through authorised pharmaceutical wholesalers. Every pen is stored in temperature-controlled facilities and shipped with appropriate cold-chain packaging to maintain medication integrity from our pharmacy to your door.

Our clinical team, led by Superintendent Pharmacist Tarun Kumar (GPhC 2233073), provides expert guidance throughout your weight loss journey. The free online consultation takes under three minutes, with prescriber review typically completed within 24 hours on working days. We believe in transparent pricing with no hidden consultation fees, membership charges, or surprise costs—the £135.00 you see for Mounjaro 15mg is your complete cost per pen.

Discreet packaging protects your privacy, with medications arriving in plain, unmarked boxes containing no external pharmacy branding or treatment information. We offer flexible delivery options across the UK, with tracking provided for every order. Should you have questions about administration technique, side effect management, or treatment progress, our pharmacy team is available via phone (+44 116 4646009) during business hours to provide professional support.

Next Steps: Starting Your Mounjaro Assessment

Beginning treatment with Mounjaro 15mg starts with a brief online consultation covering your medical history, current health status, and weight management goals. The assessment asks about conditions that may affect Mounjaro suitability, including thyroid disease, pancreatitis history, kidney function, and concurrent medications. Providing accurate, complete information ensures your prescriber can make safe, informed decisions about your treatment plan.

Once approved, your prescription is prepared by our pharmacy team and dispatched for next-day delivery where ordered before our daily cut-off time. Your first prescription will typically be for the 2.5mg starting dose, with subsequent prescriptions issued monthly as you progress through the dose escalation schedule toward 15mg maintenance therapy. Our prescribers coordinate your dosing timeline to ensure seamless treatment continuity without gaps in medication supply.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
3. Electronic Medicines Compendium. (2023). Mounjaro 15 mg solution for injection in pre-filled pen – Summary of Product Characteristics. https://www.medicines.org.uk/emc/product/14881
4. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment, dietary modification, and lifestyle factors.